Annovis Bio, Inc. (ANVS)

Every figure this model derived for ANVS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 18,728,945 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,813,295 AssetsCurrent 2024-03-31
current liabilities 6,358,709 LiabilitiesCurrent 2026-06-30
equity -4,254,618 StockholdersEquity 2026-06-30
ocf -43,339,894 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 2,592,649 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ANVS on one particular measure came for.

RatioValue
current ratio1.23
current ratio reported1.23
dilution pct68.03
ev owner earnings-1.19

What to be careful about

What this model itself distrusts about ANVS's figures. Written by the derivation as it ran, not added afterwards.